The first US hub for experimental medical treatments is coming
5 Articles
5 Articles
The Ethics of Early Access: Balancing Hope, Risk, and Evidence
When standard treatments fail, patients facing life-threatening conditions often turn to experimental therapies still under investigation. Early access programs—including compassionate use, an expanded access program, and right-to-try pathways—offer hope by providing investigational treatments outside clinical trials. Yet these programs exist at the intersection of profound ethical tensions that challenge our most fundamental values about medica…
The first US hub for experimental medical treatments is coming
A bill that allows medical clinics to sell unproven treatments has been passed in Montana. Under the legislation, doctors can apply for a license to open an experimental treatment clinic and recommend and sell therapies not approved by the Food and Drug Administration (FDA) to their patients. Once it’s signed by the governor, the law will be the most expansive in the country in allowing access to drugs that have not been fully tested. The bill…


First US Hub For Experimental Medical Treatments Is Coming
Montana has passed a bill allowing licensed clinics to offer experimental medical treatments that haven't been approved by the FDA, provided the drugs have passed phase I safety trials. MIT Technology Review reports: The bill, which was passed by the state legislature on April 29 and is expected to be signed by Governor Greg Gianforte, essentially expands on existing Right to Try legislation in the state. But while that law was originally design…
FPSA - The first US hub for experimental medical treatments is coming
A bill that allows medical clinics to sell unproven treatments has been passed in Montana. Under the legislation, doctors can apply for a license to open an experimental treatment clinic and recommend and sell therapies not approved by the Food and Drug Administration (FDA) to their patients. Once it’s signed by the governor, the law will be the most expansive in the country in allowing access to drugs that have not been fully tested. The bill…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage